Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Attack”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05304091
What this trial is testing

Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Application.

Who this might be right for
Bradykinin-mediated Angioedema
University Hospital, Lille
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Not applicableAvailableNCT07216378
What this trial is testing

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Large-scale testing (Phase 3)Study completedNCT03888755
What this trial is testing

Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Who this might be right for
Hereditary Angioedema (HAE)
Shire 8
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Large-scale testing (Phase 3)Study completedNCT02052141
What this trial is testing

Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Testing effectiveness (Phase 2)Study completedNCT01095510
What this trial is testing

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

Who this might be right for
Hereditary Angioedema (HAE)
Shire 9
Large-scale testing (Phase 3)Study completedNCT00168103
What this trial is testing

Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 126
Large-scale testing (Phase 3)Study completedNCT02865720
What this trial is testing

Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 8
Not applicableStudy completedNCT01397864
What this trial is testing

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 181
Not applicableStudy completedNCT07009262
What this trial is testing

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 88
Not applicableStudy completedNCT01108848
What this trial is testing

Patient Registry Study of Berinert® in Normal Clinical Practice

Who this might be right for
Includes: Hereditary Angioedema
CSL Behring 318
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Large-scale testing (Phase 3)Study completedNCT00225147
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic Edema
Pharming Technologies B.V. 77
Large-scale testing (Phase 3)Study completedNCT00262288
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Post-approval studies (Phase 4)Study completedNCT01457430
What this trial is testing

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Who this might be right for
Hereditary Angioedema
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Study completedNCT00289211
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 83
Large-scale testing (Phase 3)WithdrawnNCT04898309
What this trial is testing

Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
AO GENERIUM
Not applicableNo Longer AvailableNCT04583007
What this trial is testing

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Shire
Next Page